IE47791B1 - Stable solutions of hydrogenated ergopeptide alkaloids - Google Patents

Stable solutions of hydrogenated ergopeptide alkaloids

Info

Publication number
IE47791B1
IE47791B1 IE1598/78A IE159878A IE47791B1 IE 47791 B1 IE47791 B1 IE 47791B1 IE 1598/78 A IE1598/78 A IE 1598/78A IE 159878 A IE159878 A IE 159878A IE 47791 B1 IE47791 B1 IE 47791B1
Authority
IE
Ireland
Prior art keywords
solution
component
weight
mixture
water
Prior art date
Application number
IE1598/78A
Other languages
English (en)
Other versions
IE781598L (en
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of IE781598L publication Critical patent/IE781598L/xx
Publication of IE47791B1 publication Critical patent/IE47791B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE1598/78A 1977-08-06 1978-08-04 Stable solutions of hydrogenated ergopeptide alkaloids IE47791B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735587 DE2735587A1 (de) 1977-08-06 1977-08-06 Stabile loesungen und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
IE781598L IE781598L (en) 1979-02-06
IE47791B1 true IE47791B1 (en) 1984-06-27

Family

ID=6015843

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1598/78A IE47791B1 (en) 1977-08-06 1978-08-04 Stable solutions of hydrogenated ergopeptide alkaloids

Country Status (23)

Country Link
JP (1) JPS5428811A (cs)
AT (1) AT364463B (cs)
AU (1) AU525725B2 (cs)
BE (1) BE869560R (cs)
CA (1) CA1111348A (cs)
CH (1) CH635347A5 (cs)
CS (1) CS203199B2 (cs)
DE (1) DE2735587A1 (cs)
DK (1) DK337678A (cs)
FI (1) FI782341A7 (cs)
FR (1) FR2399248A2 (cs)
GB (1) GB1596948A (cs)
GR (1) GR72791B (cs)
IE (1) IE47791B1 (cs)
IL (1) IL55285A (cs)
IT (1) IT1202759B (cs)
NL (1) NL7808122A (cs)
NO (1) NO147901C (cs)
NZ (1) NZ188073A (cs)
PT (1) PT68386A (cs)
SE (1) SE444114B (cs)
YU (1) YU188378A (cs)
ZA (1) ZA784435B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930369A1 (de) * 1979-07-26 1981-02-05 Rentschler Arzneimittel Arzneimittelloesungen
DE2945636A1 (de) * 1979-11-12 1981-05-21 Sandoz-Patent-GmbH, 7850 Lörrach Stabile loesungen von hydrierten ergotalkaloiden bzw. ihren salzen und heparin bzw. seinen salzen sowie verfahren zu deren herstellung
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden
IT1200609B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano
AT381232B (de) * 1985-05-13 1986-09-10 Kwizda Fa F Johann Verfahren zur herstellung stabiler fluessiger loesungen von ergolinderivaten
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
ES2222895T3 (es) 1999-03-26 2005-02-16 Pozen, Inc. Composiciones de dihidroergotamina de alta potencia.
DE102007014947B4 (de) 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749779A (en) * 1970-08-27 1973-07-31 American Home Prod Stable solutions of sodium diphenylhydantoin

Also Published As

Publication number Publication date
NO147901C (no) 1983-07-06
GR72791B (cs) 1983-12-05
IT1202759B (it) 1989-02-09
PT68386A (en) 1978-09-01
FI782341A7 (fi) 1979-02-07
DK337678A (da) 1979-02-07
SE7808210L (sv) 1979-02-07
IL55285A (en) 1981-09-13
AT364463B (de) 1981-10-27
IE781598L (en) 1979-02-06
BE869560R (fr) 1979-02-05
NO782605L (no) 1979-02-07
SE444114B (sv) 1986-03-24
CA1111348A (en) 1981-10-27
IT7826407A0 (it) 1978-08-02
FR2399248B2 (cs) 1980-07-18
NO147901B (no) 1983-03-28
YU188378A (en) 1984-02-29
CH635347A5 (en) 1983-03-31
FR2399248A2 (fr) 1979-03-02
CS203199B2 (en) 1981-02-27
ZA784435B (en) 1980-03-26
ATA567378A (de) 1981-03-15
NZ188073A (en) 1980-12-19
AU525725B2 (en) 1982-11-25
IL55285A0 (en) 1978-10-31
DE2735587A1 (de) 1979-02-15
JPS5428811A (en) 1979-03-03
AU3867678A (en) 1980-02-07
GB1596948A (en) 1981-09-03
NL7808122A (nl) 1979-02-08

Similar Documents

Publication Publication Date Title
US4138565A (en) Stable solutions and processes for their preparation
CA1177399A (en) Injectable composition of rapamycin
AU742576B2 (en) Novel stable liquid paracetamol compositions, and method for preparing same
US5047230A (en) Aerosol composition comprising nitroglycerin as active ingredient
CA1251734A (en) Stabilized injectable solutions of piroxicam
JPWO1999002158A1 (ja) ４，５−エポキシモルヒナン誘導体を含有する安定な医薬品組成物
GB2250197A (en) Pyroxycam solutions of increased stability and without tissue-damaging effect
EP1352654B1 (en) Famotidine injections
CA1111348A (en) Solution containing a hydrogenated ergopeptide alkaloid
US4784855A (en) Pharmaceutical compositions and suppository
CA1069438A (en) Stable solutions and processes for their preparation
US4402949A (en) Stable solutions of hydrogenated ergotalkaloids
JPH0576929B2 (cs)
HU179989B (en) Process for preparing pharmacological compositions containing r-/+/-1-/1-phenyl-ethyl/-1h-imidazol-5-carboxylic acid ethyl ester for intravenous administration
JPH11189531A (ja) 経粘膜投与用医薬組成物
AU699386B2 (en) A pharmaceutical composition for lowering the blood pressure and a process for the preparation thereof
CA2217360A1 (en) Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation
IE50372B1 (en) Stable solutions of hydrogenated egotalkaloids
US4377583A (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
HU181940B (en) Process for producing solutions of vincane derivatives for parentheral application
CA3133952A1 (en) Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability
FR2456101A1 (fr) Derives dihalogenes geminaux de pyrimidin-4-one condensees, procede pour leur preparation et compositions pharmaceutiques les contenant
IE50512B1 (en) Pharmaceutical injectable composition and two-pack container for said composition
US4451458A (en) Method for the treatment of post-operative thrombosis
AU637801B2 (en) Intranasal administration of 3,3-disubstituted indolines